SCHEMBL5226060

SCHEMBL5226060

CC(C)c1cn(C)c2c(N3CCCC3=O)cc(C(=O)O)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
CYP2C9 P11712 5/20 0.40
HPGD P15428 3/20 0.40
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 1/20 0.40
CTSD P07339 1/20 0.40
BACE1 P56817 1/20 0.40
BACE2 Q9Y5Z0 1/20 0.40
IP6K1 Q92551 1/20 0.38
IP6K3 Q96PC2 1/20 0.38
IP6K2 Q9UHH9 1/20 0.38
GAA P10253 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
USP19 O94966 1/20 0.33
BRD4 O60885 1/20 0.33
BRDT Q58F21 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5217794 0.87 MAPT (0.40) ALDH1A1CYP2C9CYP3A4CTSDBACE1
SCHEMBL5223584 0.82 CTSD (0.51) ALDH1A1CYP2C9HPGDCYP3A4CYP1A2
SCHEMBL5220565 0.78 CTSD (0.42) ALDH1A1CYP2C9HPGDCYP3A4CYP1A2
SCHEMBL23809452 0.74 SLC22A12 (0.41) CYP1A2HSD17B10MEN1KMT2AACE2
SCHEMBL5220175 0.72 CTSD (0.48) ALDH1A1CYP2C9CYP3A4CTSDBACE1
SCHEMBL5219489 0.71 ALDH1A1 (0.47) ALDH1A1CYP2C9HPGDCYP3A4CYP1A2
SCHEMBL23809368 0.70 ACE2 (0.37) ACE2
SCHEMBL5217707 0.70 ALDH1A1 (0.54) ALDH1A1CYP2C9HPGDCYP3A4CYP1A2
SCHEMBL5222262 0.69 ALDH1A1 (0.50) ALDH1A1CYP2C9HPGDCYP3A4CYP1A2
SCHEMBL25352612 0.68 ALDH1A1 (0.49) ALDH1A1CYP2C9HPGDCYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed